Wantaibio: Nine-valent HPV vaccine receives approval for the first time in China.
Wan Tai Biotechnology announced that the nine-valent human papillomavirus vaccine produced by its wholly-owned subsidiary Xiamen Wan Tai Canghai Biotechnology Co., Ltd. has obtained the "Bioproducts Batch Release Certificate" issued by the China Food and Drug Inspection Research Institute. This marks the official entry of the product into the market, enriching the company's product lineup, creating new sources of revenue and profit growth, and enhancing the company's market competitiveness.
Latest